When was Bionaut Labs founded?

Bionaut Labs was founded in 2015 and raised its 1st funding round 6 years after it was founded.

Where is Bionaut Labs located?

Bionaut Labs is headquartered in Los Angeles, United States. It is registered at 1999 BRYAN ST STE 900,DALLAS,TX,75201,57.

Who is the current CEO of Bionaut Labs?

Michael Shpigelmacher of Bionaut Labs. They have also founded 1 company.

How many employees does Bionaut Labs have?

As of May 31, 2026, the latest employee count at Bionaut Labs is 26.

Is Bionaut Labs a funded company?

Bionaut Labs is a funded company, having raised a total of $63.2M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Mar 03, 2021.

When was the latest funding round of Bionaut Labs?

Bionaut Labs' latest funding was a $***** Series B round on Nov 28, 2022, with participation from 14 investors.

Where does Bionaut Labs rank among its competitors?

Bionaut Labs ranks 23rd amongst 272 active competitors, of which 79 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was NanoViricides, which secured $6M in Nov, 2025.

Who are the top competitors of Bionaut Labs?

Bionaut Labs' top competitors include Liquidia, Acorda and Genedit. Among them, NanoViricides secured the most recent funding round in November, 2025.

Bionaut Labs - 2026 Company Profile, Team, Funding & Competitors

Bionaut Labs is a series B company based in Los Angeles (United States), founded in 2015 by Aviad Maizels, Michael Shpigelmacher and Alex Shpunt. It operates as a Developer of miniature robots for drug delivery. Bionaut Labs has raised $63.2M in funding from Khosla Ventures. The company has 272 active competitors, including 79 funded and 29 that have exited. Its top competitors include companies like Liquidia, Acorda and Genedit.

Company Details

Developer of miniature robots for drug delivery. It offers advanced remote control and imaging system that helps in drug delivery to targeted disease areas and helps in the treatment of brain disorders. It also provides technology for gene therapy, CRISPR-Cas9, and oncolytic viruses.

Website: bionautlabs.com
Social
Registered Address: 1999 BRYAN ST STE 900,DALLAS,TX,75201,57

Key Metrics

Founded Year

2015

Location

Los Angeles, United States

Stage

Series B

Total Funding

$63.2M in 2 rounds

Latest Funding Round

Series B, Nov 28, 2022, $*****

Investors

Khosla Ventures & 17 more

Ranked

23^rd among 272 active competitors

Employee Count

26 as on May 31, 2026

Similar Companies

Liquidia & 358 more

View Bionaut Labs' full profile

Bionaut Labs is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BIONAUT LABS INC CIN: 32093098211 , United States, Active	Jan 03, 2024	-	-	-

Bionaut Labs has raised a total funding of $63.2M over 2 rounds. Its first funding round was on Mar 03, 2021. Its latest funding round was a Series B round on Nov 28, 2022 for $*****. 14 investors participated in its latest round. Bionaut Labs has 16 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Bionaut Labs:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 28, 2022	7592567	Series B	3116409	5980722	4320217	5121935
Mar 03, 2021	5185328	Series A	1448424	2786430	Khosla Ventures	Upfront Ventures & 3 more

Access funding benchmarks and valuations. Sign up today!

View details of Bionaut Labs's funding rounds and investors

The founders of Bionaut Labs are Aviad Maizels, Michael Shpigelmacher and Alex Shpunt. Michael Shpigelmacher is the CEO of Bionaut Labs.

Here are the details of Bionaut Labs' key team members:

Aviad Maizels: Co-Founder & Chairman of Bionaut Labs and founder of 1 other company. They serve on the board of 1 company.
Contact Info: 1 email address
Michael Shpigelmacher: Co-Founder & CEO of Bionaut Labs.
Contact Info: 1 email address
Alex Shpunt: Co-Founder of Bionaut Labs.

View details of Bionaut Labs's Founder profiles and Board Members

Bionaut Labs' employee count trend

Bionaut Labs has 26 employees as of May 26. Here is Bionaut Labs's employee count trend over the years:

Uncover Bionaut Labs' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Bionaut Labs include Liquidia, Acorda and Genedit. Here is the list of Top 10 competitors of Bionaut Labs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Liquidia 2004, Morrisville (United States), Public	Developer of therapeutics for pulmonary hypertension and cardiopulmonary conditions	$90.3M	Morningside, New Enterprise Associates & 18 others	68/100
2nd	Acorda 1995, Ardsley (United States), Acquired	Developer of therapies that restore neurological function	$66.5M	Saints Capital, EDBI & 16 others	66/100
3rd	Genedit 2016, Berkeley (United States), Series B	Developer of drug delivery system for genetic medicines	$93.5M	IMM Investment, SK & 20 others	65/100
4th	Sirnaomics 2007, Gaithersburg (United States), Public	Developer of RNA based therapeutics for the treatment of cancer and fibrosis disease	$267M	Rotating Boulder Fund, Yuexiu Group & 16 others	63/100
5th	Aera 2021, Boston (United States), Series B	Developer of genetic medicines across a wide range of therapeutic areas	$193M	Google Ventures, Lux Capital & 3 others	62/100
6th	NanoSyrinx 2018, Coventry (United Kingdom), Series A	Developer of targeted intracellular delivery platform for biological molecules	$21.6M	M Ventures, Octopus Ventures & 15 others	61/100
7th	Helex 2021, New York City (United States), Seed	Provider of next-generation gene-editing therapies	$6M	pi Ventures, IndieBio & 2 others	59/100
8th	NanoViricides 2005, West Haven (United States), Public	Targeted antiviral therapeutics	-	-	59/100
9th	Starpharma 1996, United States, Public	Biotechnology company advancing dendrimer technology for improved patient health outcomes	-	The Australian health system, HHS	56/100
10th	YolTech 2021, Shanghai (China), Series B	Developer of gene editing and LNP delivery platforms for therapeutics	$59.1M	Decheng Capital, AstraZeneca & 3 others	56/100
23rd	Bionaut Labs 2015, Los Angeles (United States), Series B	Developer of miniature robots for drug delivery	$63.2M	Khosla Ventures, Bold Capital Partners & 16 others	49/100